Test Price
2,800 AED✅ Home Collection Available
NTHL1 Gene Familial Adenomatous Polyposis Type 3 Genetic Test in Dubai | 2,800 AED | DNA Labs UAE
Executive Summary & Core Metrics
🔬 Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Post-test telephonic consultation with a DHA-licensed genetic counsellor for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS test analyses the entire coding sequence of the NTHL1 tumour suppressor gene to detect germline mutations causing familial adenomatous polyposis type 3, a hereditary colorectal cancer syndrome. Our protocol combines next-generation sequencing with confirmatory Sanger sequencing, delivering a comprehensive report in 3–4 weeks from a simple blood sample or FTA card.
| Feature | Our Test (ISO 9001:2015) | Closest Alternative |
|---|---|---|
| Precision | NGS with Sanger confirmation; ≥99% analytical sensitivity | Single-gene Sanger sequencing (limited to known hotspots) |
| Method | Full gene coverage (exons + splice junctions) by NGS | Targeted mutation panels may miss rare NTHL1 variants |
| Turnaround Speed | 3–4 weeks with expedited reporting for positive results | Often 5–6 weeks for similar comprehensive analysis |
Physician Insight & Safety Protocols
“A positive NTHL1 result requires careful clinical correlation with colonoscopic findings and family history; this test is a powerful tool for risk‑adapted surveillance, but it does not replace regular endoscopic monitoring. I strongly recommend that patients discuss implications with their oncologist or genetic counsellor before and after testing.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. This genetic test does not override current treatment plans; always follow your oncologist’s advice.
🚨 Exclusion Criteria & Emergency Red Flags
- Patients unable to provide informed consent (mandatory genetic counselling session required before sampling).
- Minors must have legal guardian consent and a court‑approved indication per UAE health regulations.
- Sample rejection if whole blood is haemolysed or FTA card is contaminated; a repeat collection will be arranged.
- Emergency red flags: Severe abdominal pain, rectal bleeding, or unexplained weight loss during the testing period – seek immediate medical attention; testing does not replace urgent evaluation.
- Positive result alone is not a cancer diagnosis; confirmatory colonoscopy and multidisciplinary team review are essential.
Patient FAQ & Clinical Guidance
1. What is the clinical purpose of the NTHL1 gene test?
This test identifies germline mutations in the NTHL1 tumour suppressor gene to confirm a hereditary predisposition to familial adenomatous polyposis type 3 and associated colorectal cancer risk. It guides tailored surveillance and preventive strategies.
2. How should I prepare for the blood sample collection?
No fasting is required; however, you must provide a detailed family cancer history and attend a genetic counselling session to draw a pedigree chart before testing. The home phlebotomy service is available daily from 8 AM to 11 PM.
3. How long does it take to receive results, and how are they delivered?
Results are ready in 3–4 weeks. A secure copy is shared with your referring physician, and you receive a telephonic guidance session with a clinical geneticist to interpret the findings.
UAE Regulatory & Data Privacy Adherence
UAE Regulatory Compliance & Facility Credentials
- DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
- Patient data handled pursuant to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – all genomic data is encrypted and stored in UAE‑based servers.
- Clinical testing safety and patient consent governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Health information systems comply with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- ISO 9001:2015 certified quality management system (Cert: INT/EGQ/2509DA/3139).
For home collection bookings or insurance verification, WhatsApp: +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | NTHL1 Gene Familial Adenomatous Polyposis Type 3 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | Z15.09 |
| LOINC Code | 58130-9 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians